| Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus | 2021-05-06 | 2023-05-22 | |
| A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL) | 2021-01-26 | 2023-05-18 | |
| Study of VIB7734 for the Treatment of Moderate to Severely Active SLE | 2021-06-24 | 2023-05-16 | |
| A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma | 2019-05-08 | 2023-03-31 | 2024-03-25 |
| Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma | 2019-09-16 | 2023-03-23 | 2023-12-14 |
| A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis | 2021-03-24 | 2023-02-28 | 2023-12-14 |
| A Study to Evaluate ABP 938 and Aflibercept (Eylea®) in Participants With Chorioretinal Vascular Disease (CVD) | 2023-01-23 | 2023-02-17 | |
| Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria | 2021-04-15 | 2022-12-20 | 2024-04-08 |
| Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis. | 2018-12-31 | 2022-12-19 | 2023-12-14 |
| A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis | 2021-10-04 | 2022-12-19 | 2023-12-14 |
| A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache | 2019-10-07 | 2022-12-01 | 2023-09-14 |
| Study of Early Relapsed, Lenalidomide-refractory Subjects Eligible for Carfilzomib Triplet | 2020-08-06 | 2022-11-30 | 2023-10-18 |
| A Study of ABP 215 Versus Bevacizumab in Chinese Subjects With Advanced Non-Squamous Non-Small Cell Lung Cancer | 2021-05-15 | 2022-11-13 | |
| A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome | 2019-10-16 | 2022-09-01 | |
| Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200). | 2020-06-04 | 2022-08-02 | 2023-04-17 |
| A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD] | 2020-06-22 | 2022-07-18 | 2023-12-14 |
| A Study Evaluating the Efficacy and Safety of ABP 959 Compared With Eculizumab in Adult Participants With PNH | 2019-01-22 | 2022-07-12 | 2023-03-23 |
| Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis | 2018-12-19 | 2022-04-25 | 2023-10-03 |
| Open-label Extension of Study 20130173 of Denosumab in Children and Young Adults With Osteogenesis Imperfecta | 2018-07-26 | 2022-03-28 | 2022-10-24 |
| Fourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries | 2017-03-13 | 2022-03-04 | 2022-11-17 |
| A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis | 2020-11-11 | 2022-01-13 | 2023-11-23 |
| Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study | 2020-07-28 | 2021-12-27 | 2023-08-01 |
| Safety and Tolerability of Inebilizumab, VIB4920, or the Combination in Highly Sensitized Candidates Awaiting Kidney Transplantation From a Deceased Donor | 2019-12-27 | 2021-12-23 | |
| Safety and Efficiency of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis | 2018-05-07 | 2021-12-13 | |
| A Study to Evaluate the Impact of Apremilast on Magnetic Resonance Imaging (MRI) Outcomes in Adults With Psoriatic Arthritis | 2019-02-06 | 2021-10-26 | 2022-10-18 |
| Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients | 2019-05-15 | 2021-10-01 | 2022-09-29 |
| An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis | 2019-02-11 | 2021-09-23 | 2022-10-21 |
| Talimogene Laherparepvec With Pembrolizumab in Melanoma Following Progression on Prior Anti-PD-1 Based Therapy (MASTERKEY-115) (Mk-3475-A07/KEYNOTE-A07). | 2020-01-22 | 2021-08-19 | 2022-08-15 |
| Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients | 2020-11-24 | 2021-08-03 | 2022-05-24 |
| Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine | 2019-12-04 | 2021-07-28 | 2022-05-27 |
| Pembrolizumab With Talimogene Laherparepvec or Placebo in Unresected Melanoma | 2014-12-08 | 2021-03-11 | 2022-03-08 |
| A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Japanese Subjects With Palmoplantar Pustulosis | 2019-10-16 | 2021-01-18 | 2021-12-09 |
| Imaging of Coronary Plaques in Participants Treated With Evolocumab | 2018-11-19 | 2020-12-18 | 2021-10-27 |
| A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis | 2019-03-15 | 2020-05-12 | 2022-01-25 |
| A Phase 3B, Open-label, Single-arm Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Psoriasis That is Not Adequately Controlled by Topical Therapy | 2019-06-17 | 2020-05-08 | 2021-12-20 |
| Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed Dyslipidemia | 2019-05-09 | 2020-04-24 | 2021-07-26 |
| A Controlled Trial of Erenumab in Migraine Prevention | 2019-04-12 | 2020-03-16 | 2021-01-29 |
| Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL | 2017-01-23 | 2020-03-12 | 2020-12-18 |
| Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy | 2019-03-11 | 2020-03-06 | 2021-04-26 |
| A Study of Carfilzomib Plus Dexamethasone in Adults With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers | 2018-07-05 | 2020-01-16 | 2020-12-14 |
| Effect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT) | 2018-05-23 | 2019-09-30 | 2020-08-20 |
| Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma. | 2017-06-13 | 2019-07-14 | 2020-07-13 |
| Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia | 2017-05-22 | 2019-07-09 | 2020-06-25 |
| A Study of Ivabradine in African-American/ Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction. | 2017-09-28 | 2019-04-19 | 2020-03-25 |
| A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis | 2018-02-06 | 2019-04-11 | 2020-03-24 |
| Safety and Efficacy of Blinatumomab in Adults With Newly Diagnosed High-risk Diffuse Large B-Cell Lymphoma | 2017-03-13 | 2019-04-04 | 2020-03-12 |
| Carfilzomib in Combination With Dexamethasone (Kd) in Chinese Patients With Relapsed & Refractory Multiple Myeloma | 2017-03-31 | 2018-11-05 | 2019-11-04 |
| Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention | 2017-09-06 | 2018-10-16 | 2020-01-24 |
| A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp | 2017-05-16 | 2018-08-13 | 2019-08-12 |
| Trial Assessing Long Term USe of PCSK9 Inhibition in Subjects With Genetic LDL Disorders | 2012-06-01 | 2018-05-11 | 2018-12-14 |